Morgan Stanley analyst Thibault Boutherin maintained a Hold rating on Merck KGaA today and set a price target of €135.00. Boutherin covers the Heal......

British drugmaker AstraZeneca ($AZN), fresh off a record-high stock price, continues to draw interest from U.S. and European investors thanks to, a......

Shares of Novo Nordisk ($NVO) are up 3% at the time of writing after the Centers for Medicare & Medicaid Services (CMS) announced price cuts across......

Merck ($MRK) stock rose about 4% on Monday, as of writing, after top Wells Fargo analyst Mohit Bansal upgraded his rating for the pharma company to......

A-Mark Precious Metals ( ($AMRK) ) has provided an update. On November 21, 2025, A-Mark Precious Metals announced its decision to transfer the list......

In a report released yesterday, from Deutsche Bank maintained a Hold rating on Merck & Company, with a price target of $111.00. In addition to Deut......

Marker Therapeutics ( ($MRKR) ) has released its Q3 earnings. Here is a breakdown of the information Marker Therapeutics presented to its investors......

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Merck & Company, with a price target of $95.00. Meacham covers the ......

Marks Electrical Group Plc ( ($GB:MRK) ) has issued an announcement. Marks Electrical Group plc is responding to an investigation by the Competitio......

Bernstein analyst Florent Cespedes maintained a Hold rating on Merck KGaA today and set a price target of €135.00. Cespedes covers the Healthcare s......